| scholarly article | Q13442814 |
| P2093 | author name string | Daniel J Guerra | |
| P2860 | cites work | The immune response in autism: a new frontier for autism research | Q22241718 |
| Tumor suppressor function of laminin-binding alpha-dystroglycan requires a distinct beta3-N-acetylglucosaminyltransferase | Q24312078 | ||
| Expression of the novel Golgi protein GoPro49 is developmentally regulated during mesenchymal differentiation | Q24316496 | ||
| Mouse neurexin-1alpha deletion causes correlated electrophysiological and behavioral changes consistent with cognitive impairments | Q24328996 | ||
| Common variants conferring risk of schizophrenia | Q24614376 | ||
| Rett syndrome and MeCP2: linking epigenetics and neuronal function | Q24616417 | ||
| LRRTMs and neuroligins bind neurexins with a differential code to cooperate in glutamate synapse development | Q24621537 | ||
| Recurrent rearrangements in synaptic and neurodevelopmental genes and shared biologic pathways in schizophrenia, autism, and mental retardation | Q24629022 | ||
| Strong association of de novo copy number mutations with autism | Q24633543 | ||
| Common variants on chromosome 6p22.1 are associated with schizophrenia | Q24641881 | ||
| The synaptic proteins neurexins and neuroligins are widely expressed in the vascular system and contribute to its functions | Q24643504 | ||
| CDKL5 expression is modulated during neuronal development and its subcellular distribution is tightly regulated by the C-terminal tail | Q24651382 | ||
| Maternal immune activation alters fetal brain development through interleukin-6. | Q24653759 | ||
| Identifying autism loci and genes by tracing recent shared ancestry | Q24655308 | ||
| Structural variation of chromosomes in autism spectrum disorder | Q24656970 | ||
| Rett syndrome and the MECP2 gene | Q24680354 | ||
| The Shank family of scaffold proteins | Q28144084 | ||
| The Shank family of postsynaptic density proteins interacts with and promotes synaptic accumulation of the beta PIX guanine nucleotide exchange factor for Rac1 and Cdc42 | Q28181795 | ||
| Multiple pathways regulate MeCP2 expression in normal brain development and exhibit defects in autism-spectrum disorders | Q28239845 | ||
| The RING finger protein, RNF8, interacts with retinoid X receptor alpha and enhances its transcription-stimulating activity | Q28246541 | ||
| Inflammatory response in the hippocampus of PS1M146L/APP751SL mouse model of Alzheimer's disease: age-dependent switch in the microglial phenotype from alternative to classic. | Q53297957 | ||
| Epigenetics at the epicenter of modern medicine | Q80893886 | ||
| Common polygenic variation contributes to risk of schizophrenia and bipolar disorder | Q28250609 | ||
| Biased gene conversion and the evolution of mammalian genomic landscapes | Q28252880 | ||
| Association by guilt: identification of DLX5 as a target for MeCP2 provides a molecular link between genomic imprinting and Rett syndrome | Q28256313 | ||
| Association between microdeletion and microduplication at 16p11.2 and autism | Q28264205 | ||
| Epigenetics in the nervous system | Q28300652 | ||
| Roles of fragile X mental retardation protein in dopaminergic stimulation-induced synapse-associated protein synthesis and subsequent alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-4-propionate (AMPA) receptor internalization | Q28396707 | ||
| Postsynaptic shank antagonizes dendrite branching induced by the leucine-rich repeat protein Densin-180 | Q28570182 | ||
| Presynaptic targeting of alpha4beta 2 nicotinic acetylcholine receptors is regulated by neurexin-1beta | Q28592960 | ||
| Model of autism: increased ratio of excitation/inhibition in key neural systems | Q29547530 | ||
| Epigenetics in cancer | Q29547853 | ||
| The binding of the PDZ tandem of syntenin to target proteins. | Q30439757 | ||
| Chromosome 15q11-13 duplication syndrome brain reveals epigenetic alterations in gene expression not predicted from copy number. | Q30485771 | ||
| Association and mutation analyses of 16p11.2 autism candidate genes | Q33412368 | ||
| Gene-network analysis identifies susceptibility genes related to glycobiology in autism | Q33459263 | ||
| Autism genetics: emerging data from genome-wide copy-number and single nucleotide polymorphism scans | Q33515390 | ||
| Tapping into the glial reservoir: cells committed to remaining uncommitted | Q33643732 | ||
| MeCP2 is required for normal development of GABAergic circuits in the thalamus | Q33841359 | ||
| Global methylation profiling of lymphoblastoid cell lines reveals epigenetic contributions to autism spectrum disorders and a novel autism candidate gene, RORA, whose protein product is reduced in autistic brain | Q34017168 | ||
| A de novo 1p34.2 microdeletion identifies the synaptic vesicle gene RIMS3 as a novel candidate for autism | Q34064491 | ||
| Posttranslational modification of alpha-dystroglycan, the cellular receptor for arenaviruses, by the glycosyltransferase LARGE is critical for virus binding. | Q34123911 | ||
| Role of the orphan nuclear receptor ROR alpha in the control of the metastatic behavior of androgen-independent prostate cancer cells | Q34143519 | ||
| Peptide-MHC class II complex stability governs CD4 T cell clonal selection | Q34284473 | ||
| Autism and tuberous sclerosis | Q34371013 | ||
| Cortical serotonin 5-HT2A receptor binding and social communication in adults with Asperger's syndrome: an in vivo SPECT study | Q34519364 | ||
| Epilepsy and mental retardation limited to females with PCDH19 mutations can present de novo or in single generation families | Q34611842 | ||
| CpG methylation in neurons: message, memory, or mask? | Q34660398 | ||
| Recurrent 16p11.2 microdeletions in autism | Q34729775 | ||
| Aberrant beta-catenin signaling in tuberous sclerosis | Q35084861 | ||
| Autism as a paradigmatic complex genetic disorder | Q35918574 | ||
| Reelin glycoprotein: structure, biology and roles in health and disease | Q35975662 | ||
| Identification of novel autism candidate regions through analysis of reported cytogenetic abnormalities associated with autism | Q36277199 | ||
| Autism and cytogenetic abnormalities: solving autism one chromosome at a time | Q36772011 | ||
| Dynamic weighting in Monte Carlo and optimization | Q36800239 | ||
| Congenital disorders of glycosylation: a rapidly expanding disease family | Q36824084 | ||
| Dysregulation of mTOR signaling in fragile X syndrome | Q36879282 | ||
| NF-protocadherin and TAF1 regulate retinal axon initiation and elongation in vivo | Q36927950 | ||
| Epigenetics: what is it and why is it important to mental disease? | Q37087126 | ||
| Tuberous sclerosis complex activity is required to control neuronal stress responses in an mTOR-dependent manner | Q37215418 | ||
| Positive and negative regulation of antigen receptor signaling by the Shc family of protein adapters | Q37631699 | ||
| Autism spectrum disorders and epigenetics | Q37774087 | ||
| Mutational analysis of the MECP2 gene in Tunisian patients with Rett syndrome: a novel double mutation | Q39001896 | ||
| MeCP2 involvement in the regulation of neuronal alpha-tubulin production | Q39890212 | ||
| Mutations in the calcium-related gene IL1RAPL1 are associated with autism | Q39938403 | ||
| Investigation of the expression of genes affecting cytomatrix active zone function in the amygdala in schizophrenia: effects of antipsychotic drugs | Q39980724 | ||
| Rett syndrome-causing mutations in human MeCP2 result in diverse structural changes that impact folding and DNA interactions. | Q40088472 | ||
| Retinoic acid-inducible gene I mediates early antiviral response and Toll-like receptor 3 expression in respiratory syncytial virus-infected airway epithelial cells | Q40208138 | ||
| Genomic and functional profiling of duplicated chromosome 15 cell lines reveal regulatory alterations in UBE3A-associated ubiquitin-proteasome pathway processes | Q40323242 | ||
| Negative regulation of the retinoic acid-inducible gene I-induced antiviral state by the ubiquitin-editing protein A20. | Q40348165 | ||
| Fragile X mental retardation protein regulates the levels of scaffold proteins and glutamate receptors in postsynaptic densities | Q42042937 | ||
| A longitudinal examination of the neurodevelopmental impact of prenatal immune activation in mice reveals primary defects in dopaminergic development relevant to schizophrenia. | Q43182549 | ||
| The postsynaptic NMDA-receptor--PSD-95 signaling complex in excitatory synapses of the brain. | Q43546599 | ||
| IL-1 receptor antagonist protects against placental and neurodevelopmental defects induced by maternal inflammation. | Q43678528 | ||
| Age- and infection-related maturation of the nasal immune response in 0-2-year-old children | Q43868348 | ||
| Transmission disequilibrium studies of the serotonin 5-HT2A receptor gene (HTR2A) in autism | Q43938271 | ||
| The role of Reelin in pathology of autism | Q44194128 | ||
| Association of family history of autoimmune diseases and autism spectrum disorders. | Q44723499 | ||
| Evolutionary expansion and specialization of the PDZ domains | Q45226369 | ||
| Oleic acid reversibly opens the blood-brain barrier | Q46050721 | ||
| Serotonin and dopamine transporter binding in children with autism determined by SPECT. | Q46405764 | ||
| Shank expression is sufficient to induce functional dendritic spine synapses in aspiny neurons. | Q46425942 | ||
| Glia as a therapeutic target: selective suppression of human amyloid-beta-induced upregulation of brain proinflammatory cytokine production attenuates neurodegeneration. | Q46890625 | ||
| The Angelman syndrome ubiquitin ligase localizes to the synapse and nucleus, and maternal deficiency results in abnormal dendritic spine morphology | Q46947846 | ||
| Wnt/beta-catenin signaling regulates cytokine-induced human inducible nitric oxide synthase expression by inhibiting nuclear factor-kappaB activation in cancer cells | Q47967398 | ||
| Plasma serotonin in autism | Q48434485 | ||
| Focus issue: teaching tools and learning opportunities | Q48561310 | ||
| Copy number and sequence variants implicate APBA2 as an autism candidate gene | Q50305678 | ||
| Rai1 deficiency in mice causes learning impairment and motor dysfunction, whereas Rai1 heterozygous mice display minimal behavioral phenotypes. | Q50313568 | ||
| Screening for genomic rearrangements and methylation abnormalities of the 15q11-q13 region in autism spectrum disorders | Q50341879 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | autism spectrum disorder | Q1436063 |
| P304 | page(s) | 398636 | |
| P577 | publication date | 2011-05-17 | |
| P1433 | published in | Autism Research & Treatment | Q26841817 |
| P1476 | title | The molecular genetics of autism spectrum disorders: genomic mechanisms, neuroimmunopathology, and clinical implications | |
| P478 | volume | 2011 |
Search more.